Immunocytochemical detection of 14-3-3 in primary nervous system tumors

Journal of Neuro-Oncology

Volumn 77, Issue 2, 2006, Pages 125-130

  Cao, Wei Dong ^a   Zhang, Xiang ^a   Zhang, Jian Ning ^a   Yang, Zhi Jun ^b   Zhen, Hai Ning ^a   Cheng, Guang ^a   Li, Bian ^a   Gao, Dakuan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

14 3 3 proteins; Apoptosis; Brain tumors; Immunohistochemistry

Indexed keywords

FORMALDEHYDE; PARAFFIN; PROTEIN 14 3 3; PROTEIN ANTIBODY; TUMOR MARKER; YWHAB PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; ASTROCYTOMA; CANCER GRADING; CHOROID PLEXUS PAPILLOMA; CONTROLLED STUDY; CRANIOPHARYNGIOMA; DRUG TARGETING; EPENDYMOMA; GLIA CELL; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MEDULLOBLASTOMA; MENINGIOMA; NERVOUS SYSTEM TUMOR; NEURILEMOMA; NEUROFIBROMA; OLIGODENDROGLIOMA; PINEAL BODY TUMOR; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; UPREGULATION; BIOSYNTHESIS; BRAIN TUMOR; COMPARATIVE STUDY; IMMUNOHISTOCHEMISTRY; METABOLISM;

14-3-3 PROTEINS; BRAIN NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; TUMOR MARKERS, BIOLOGICAL;

EID: 33747849955     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-9027-7     Document Type: Article

References (34)

1. Aitken A, Collinge DB, van Heusden BP, Isobe T, Roseboom PH, Rosenfeld G, Soll J, 14-3-3 proteins: A highly conserved, widespread family of eukaryotic proteins Trend Biochem Sci 17:498-501, 1992
2. Ferl RJ, Manak MS, Reyes MF, The 14-3-3s Genome Biol 3:3010.1-3010.7, 2002
3. Moore BW, Perez VJ, 1967 Specific acid proteins in the nervous system. In: Carlson FD, ed Physiological and Biochemical Aspects of Nervous Integration. Prentice Hall/Woods Hole, Woods Hole, pp 343-359
4. van Hemert MJ, Steensma HY, van Heusden GP, 14-3-3 proteins: Key regulators of cell division, signalling and apoptosis Bioessays 23:936-946, 2001
5. Boston PF, Jackson P, Kynoch PAM, Thompson RJ, Purification, properties, and immunohistochemical localisation of human brain 14-3-3 protein J Neurochem 38:1466-1474, 1982
6. Baxter HC, Fraser JR, Liu WG, Forster JL, Clokie S, Steinacker P, Otto M, Bahn E, Wiltfang J, Aitken A, Specific 14-3-3 isoform detection and immunolocalization in prion diseases Biochem Soc Trans 30:387-391, 2002
7. Fu H, Subramanian RR, Masters SC, 14-3-3 proteins: Structure, function, and regulation Annu Rev Pharmacol Toxicol 40:617-647, 2000
8. Martin H, Patel Y, Jones D, Howell S, Robinson K, Aitken A, Antibodies against the major brain isoforms of 14-3-3 protein. An antibody specific for the N-acetylated amino-terminus of a protein FEBS Lett 331:296-303, 1993
9. Pozuelo Rubio M, Geraghty KM, Wong BH, Wood NT, Campbell DG, Morrice N, Mackintosh C, 14-3-3-Affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation, and trafficking Biochem J 379:395-408, 2004
10. Hermeking H, The 14-3-3 cancer connection Nat Rev Cancer 3:931-43, 2003
11. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ, Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL Cell 87:619-628, 1996
12. Xing H, Zhang S, Weinheimer C, Kovacs A, Muslin AJ, 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades EMBO J 19:349-358, 2000
13. Subramanian RR, Masters SC, Zhang H, Fu H, Functional conservation of 14-3-3 isoforms in inhibiting Bad-induced apoptosis Experimental Cell Research 271:142-151, 2001
14. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME, Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor Cell 96:857-868, 1999
15. Basu S, Totty NF, Irwin MS, Sudol M, Downward J, Akt phophorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis Mol Cell 11:11-23, 2003
16. Zhang L, Chen J, Fu H, Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins Proc Natl Acad Sci USA 96:8511-8515, 1999
17. Nomura M, Shimizu S, Sugiyama T, Narita M, Ito T, Matsuda H, Tsujimoto Y, 14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax J Biol Chem 278:2058-2065, 2003
18. Craparo A, Freund R, Gustafson TA, 14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner J Biol Chem 272:11663-11669, 1997
19. Bonnefoy-Berard N, Liu YC, von Willebrand M, Sung A, Elly C, Mustelin T, Yoshida H, Ishizaka K, Altman A, Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells Proc Natl Acad Sci U S A 92:10142-10146, 1995
20. Zhang P., Chan SL, Fu W, Mendoza M, Mattson MP, TERT suppresses apoptotis at a premitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein binding ability FASEB J 17:767-769, 2003
21. Beyaert R, Heyninck K, Van Huffel S, A20 and A20-binding proteins as cellular inhibitors of nuclear factor-κB-dependent gene expression and apoptosis Biochem. Pharmacol. 60:1143-1151, 2000
22. Kleihues P, Cavenee WK, Pathology and genetics of tumours of the nervous system. LARC Press, Lyon, 2000, pp 6-7
23. Kawamoto Y, Akiguchi I, Nakamura S, Honjyo Y, Shibasaki H, Budka H, 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains J Neuropathol Exp Neurol 61:245-253, 2002
24. Kawamoto Y, Akiguchi I, Nakamura S, Budka H, Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy Ann Neurol 52:722-731, 2002
25. Remmele W, Hildebrand U, Hienz HA, Klein PJ, Vierbuchen M, Behnken LJ, Heicke B, Scheidt E, Comparative histological, histochemical, immunhistochemical and biochemical studies on estrogen receptors, lectin receptors, and Barr bodies in human breast cancer Virchows Arch 409:127-147, 1986
26. Boston PF, Jackson P, Thompson RJ, Human 14-3-3 protein: radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders J Neurochem 38:1475-1482, 1982
27. Kawamoto Y, Akiguchi I, Kovacs GG, Flicker H, Budka H, Increased 14-3-3 immunoreactivity in glial elements in patients with multiple sclerosis Acta Neuropathol (Berl) 107:137-143, 2004
28. Rudin CM, Thompson CB, Apoptosis and disease: Regulation and clinical relevance of programmed cell death Annu Rev Med 48:267-281, 1997
29. Newton HB, Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4:p53 signaling pathway Expert Rev Anticancer Ther 5:177-191, 2005
30. Johnson MD, Okedli E, Woodard A, Toms SA, Allen GS, Evidence for phosphatidylinositol 3-kinase-Akt-p7S6 K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in meningioma cells J Neurosurg 97:668-675, 2002
31. Mawrin C, Kirches E, Dietzmann K, Roessner A, Boltze C, Expression pattern of apoptotic markers in vestibular schwannomas Pathol Res Pract 198:813-819. 2002
32. Kulig E, Jin L, Qian X, Horvath E, Kovacs K, Stefaneanu L, Scheithauer BW, Lloyd RV, Apoptosis in nontumorous and neoplastic human pituitaries: expression of the Bcl-2 family of proteins Am J Pathol 154:767-774, 1999
33. Nakasu S, Matsumura K, Nioka H, Handa J, Lectin binding and bcl-2 protein expression in craniopharyngiomas Neurol Med Chir (Tokyo) 34:429-435, 1994
34. Masters SC, Fu H, Survival-promoting functions of 14-3-3 proteins Biochem Soc Trans 30:360-365, 2002